Chugai Pharmaceutical Co.

Chugai Pharmaceutical Co., Ltd.
Native name
中外製薬株式会社
Chūgai Seiyaku kabushiki gaisha
Company typePublic KK
IndustryPharmaceutical Industry, Business import, production and development of drugs for medical sales
FoundedMarch 8, 1943; 81 years ago (1943-03-08)
HeadquartersNihonbashi Mitsui Tower, Nihonbashi Muromachi 2-1-1, Chūō, Tokyo
On the registration Headquarter: Tokyo Kita (Tokyo)
Key people
Osamu Nagayama - Chairman and Tatsuro Kosaka - CEO
Revenue72.9 billion capital of 47 million yen. Standalone sales of 329.2 billion yen and 344.8 billion yen consolidated
(December 2007)
ParentHoffmann-La Roche (61.62%)
Websitewww.chugai-pharm.co.jp (in Japanese)

Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014.[1] The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.

  1. ^ Cortez, Michelle Fay; Matsuyama, Kanoko (25 August 2014). "Roche Said to Have Decided Against Bid for Rest of Chugai". Bloomberg.